Multidisciplinary
Published in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques • May 1, 2015
NobleIDNI2P62W39R26S83
Authors:,,
Frederick A. Zeiler
Nick Sader
LM Gillman
Abstract
Introduction: Ketamine, an N-methyl D-aspartate (NMDA) receptor antagonist, carries potential benefit in patients with neurological illness. The cerebrovascular/cerebral blood flow (CBF) response to ketamine has been poorly outlined in the literature. Methods: We performed a systematic review of the...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!